Related references
Note: Only part of the references are listed.The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin
Mei-Chin Chen et al.
BIOMATERIALS (2009)
Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate
Rishi Paliwal et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Oral delivery of low molecular weight heparin microspheres prepared using biodegradable polymer matrix system
Satya Surya Shankar Lanke et al.
JOURNAL OF MICROENCAPSULATION (2009)
Synthesis and Evaluation of Pegylated Dendrimeric Nanocarrier for Pulmonary Delivery of Low Molecular Weight Heparin
Shuhua Bai et al.
PHARMACEUTICAL RESEARCH (2009)
Oral low molecular weight heparin delivery by microparticles from complex coacervation
Alf Lamprecht et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2007)
Liphophilic complexation of heparin based on bile acid for oral delivery
Dong Yun Lee et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Absorption study of deoxycholic acid-heparin conjugate as a new form of oral anti-coagulant
Sang Kyoon Kim et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Epithelial heparin delivery via microspheres mitigates experimental colitis in mice
Yann Pellequer et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Low molecular weight heparin loaded pH-sensitive microparticles
Yvette Meissner et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
N-sulfonato-N,O-carboxymethylchitosan:: A novel polymeric absorption enhancer for the oral delivery of macromolecules
M. Thanou et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Preparation and evaluation of oral solid heparin using emulsifier and adsorbent for in vitro and in vivo studies
Yukako Ito et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
The quest for non-invasive delivery of bioactive macromolecules: A focus on heparins
Nusrat A. Motlekar et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Oral bioavailability of a low molecular weight heparin using a polymeric delivery system
Valerie Hoffart et al.
JOURNAL OF CONTROLLED RELEASE (2006)
被撤回的出版物: Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin (Retracted Article. See vol 16, pg 723, 2008)
Nusrat A. Motlekar et al.
JOURNAL OF DRUG TARGETING (2006)
Efficacy of orally active chemical conjugate of low molecular weight heparin and deoxycholic acid in rats, mice and monkeys
YK Lee et al.
JOURNAL OF CONTROLLED RELEASE (2006)
被撤回的出版物: Evaluation of the oral bioavailability of low molecular weight heparin formulated with glycyrrhetinic acid as permeation enhancer (Retracted article. See vol. 69, pg. 535, 2008)
Nusrat A. Motlekar et al.
DRUG DEVELOPMENT RESEARCH (2006)
Polycationic lipophilic-core dendrons as penetration enhancers for the oral administration of low molecular weight heparin
PY Hayes et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Oral delivery of chemical conjugates of heparin and deoxycholic acid in aqueous formulation
SK Kim et al.
THROMBOSIS RESEARCH (2006)
Heparin-loaded zein microsphere film and hemocompatibility
HJ Wang et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Tricaprylin microemulsion for oral delivery of low molecular weight heparin conjugates
SK Kim et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Oral heparin delivery:: Design and in vivo evaluation of a stomach-targeted mucoadhesive delivery system
T Schmitz et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
被撤回的出版物: Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels (Retracted Article. See vol 16, pg 723, 2008)
NA Motlekar et al.
JOURNAL OF DRUG TARGETING (2005)
Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and β-amyloid accumulation in a mouse model of Alzheimer's disease
L Bergamaschini et al.
JOURNAL OF NEUROSCIENCE (2004)
Oral delivery of heparin: SNAC and related formulations
G Pineo et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2004)
Targeted delivery of heparin and LMWH using a fibrin antibody prevents restenosis
AC Thomas et al.
ATHEROSCLEROSIS (2004)
New anticoagulants for treatment of venous thromboembolism
JI Weitz
CIRCULATION (2004)
Study of the micellization behavior of different order amino block copolymers with heparin
MH Dufresne et al.
PHARMACEUTICAL RESEARCH (2004)
Permeation enhancing polymers in oral delivery of hydrophilic macromolecules:: thiomer/GSH systems
A Bernkop-Schnürch et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Oral heparin administration with a novel drug delivery agent (SNAC) in healthy volunteers and patients undergoing elective total hip arthroplasty
SD Berkowitz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil
CE Kast et al.
PHARMACEUTICAL RESEARCH (2003)
Challenges for the oral delivery of macromolecules
M Goldberg et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
ATTEMPTS: a heparin/protamine-based triggered release system for the delivery of enzyme drugs without associated side-effects
YJ Park et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Microencapsulation of low molecular weight heparin into polymeric particles designed with biodegradable and nonbiodegradable polycationic polymers
V Hoffart et al.
DRUG DELIVERY (2003)
Pathway of oral absorption of heparin with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate
D Malkov et al.
PHARMACEUTICAL RESEARCH (2002)
Heparin attenuates cytotoxic and inflammatory activity of Alzheimer amyloid-β in vitro
L Bergamaschini et al.
NEUROBIOLOGY OF AGING (2002)
Nasal administration of low molecular weight heparin
J Arnold et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Delivery of LMW heparin via surface coated chitosan/peg-alginate microspheres prevents thrombosis
T Chandy et al.
DRUG DELIVERY (2002)
In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits
YY Jiao et al.
CIRCULATION (2002)
Conjugation of low-molecular-weight heparin and deoxycholic acid for the development of a new oral anticoagulant agent
YK Lee et al.
CIRCULATION (2001)
Physiological transport forces govern drug distribution for stent-based delivery
CW Hwang et al.
CIRCULATION (2001)
Development of oral heparin therapy for prophylaxis and treatment of deep venous thrombosis
SR Money et al.
CARDIOVASCULAR SURGERY (2001)
Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis
L Borsig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Oral delivery of new heparin derivatives in rats
YK Lee et al.
PHARMACEUTICAL RESEARCH (2000)
Treatment of experimentally induced caval thrombosis with oral low molecular weight heparin and delivery agent in a porcine model of deep venous thrombosis
K Salartash et al.
ANNALS OF SURGERY (2000)
Share Paper
